Hakan Özdoğu - Concepedia

Author

Hakan Özdoğu

Also Known As

H Ozdoğu, H. OZDOGU, H. Ozdogu, H. Özdogu, H. Özdoğu, HAKAN OZDOGU, HAKAN ÖZDOĞU, Hakan Ozdogu, Hakan Ozdoğu, Hakan ÖZDOĞU

179

Publications

Citations

H-Index

Concepts

All Affiliations

Başkent University Sheba Medical Center Sorbonne Université Inserm Başkent University Hospital

HÖ

About

Hakan Özdoğu is an author at Başkent University specializing in medicine, hematology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	29	1K
2	Health Sciences	7	7	505
3	Public Health	3	3	64
4	Engineering	1	1	23
5	Natural Sciences	1	1	28

Hakan Özdoğu

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial Philippe Moreau, Meletios Α. Dimopoulos, Joseph Mıkhael, The Lancet Hematological MalignancyRelapsed Multiple MyelomaMedicineRandomised Phase 3Immunology	2021	366
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group Meral Beksaç, Rauf Haznedar, Tülin Firatli‐Tuglular, European Journal Of Haematology	2010	143
Prophylactic red blood cell exchange may be beneficial in the management of sickle cell disease in pregnancy Süheyl Asma, İlknur Kozanoğlu, Ebru Tarım, Transfusion	2014	54
RHINO-ORBITAL-CEREBRAL MUCORMYCOSIS WITH DIFFERENT CEREBRAL INVOLVEMENTS: INFARCT, HEMORRHAGE, AND OPHTHALMOPLEGIA Zafer Koç, Filiz Koç, Deniz Yerdelen, International Journal of Neuroscience	2007	53
Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia Arnon Nagler, Abraham S. Kanate, Myriam Labopin, Haematologica Cell TherapyAnti-thymocyte GlobulinTransplantationMarrow TransplantationHaploidentical Transplantation	2020	51
Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study Michael H. Albert, Tiarlan Sirait, Dirk-Jan Eikema, Blood	2022	51
Human bone marrow mesenchymal cells express NG2: possible increase in discriminative ability of flow cytometry during mesenchymal stromal cell identification İlknur Kozanoğlu, Can Boğa, Hakan Özdoğu, Cytotherapy Flow CytometryPossible IncreaseAdult Stem CellImmunologyHematology	2009	49
Post‐transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA‐identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Giorgia Battipaglia, Myriam Labopin, Rose‐Marie Hamladji, Cancer	2020	43
Clinical significance of circulating blood and endothelial cell microparticles in sickle-cell disease Mutlu Kasar, Can Boğa, Mahmut Yeral, Journal of Thrombosis and Thrombolysis ImmunohematologyLaboratory HematologyHealth SciencesSickle-cell DiseaseHematology	2013	39
Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party Marie Thérèse Rubio, Maud D’Aveni, Myriam Labopin, Journal of Hematology & Oncology	2017	39

Page 1